Alan Wookey | September 16, 2019

Successful Companion Diagnostics Programs: Experiences of a Global Central Laboratory

World CDx Boston 2019
This presentation reviews the central laboratory’s role and best practices for executing companion diagnostics globally. It focuses on key attributes required for complex oncology trials, and highlights CDx development in China. Q2 Solutions presented this during the World CB and CDx Boston 2019 conference.

Download this presentation to learn more.

Alan Wookey, Companion Diagnostics and Oncology Scientific Advisor

Related Services:
Companion Diagnostic Development: Current trends and recommendations

The Power of the Central Laboratory for Immuno-Oncology Drug Development

Clinical Trials Laboratories in the Immuno-Oncology Setting

Increased demands lead to increased opportunities

Read More